These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11451676)

  • 1. Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Aralar P; Young LS
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2210-4. PubMed ID: 11451676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.
    Bermudez LE; Kolonoski P; Wu M; Aralar PA; Inderlied CB; Young LS
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1870-4. PubMed ID: 10428905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.
    Bermudez LE; Inderlied CB; Kolonoski P; Wu M; Barbara-Burnham L; Young LS
    Antimicrob Agents Chemother; 1996 Mar; 40(3):546-51. PubMed ID: 8851568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice.
    Bermudez LE; Nash K; Petrofsky M; Young LS; Inderlied CB
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2619-22. PubMed ID: 10991834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC) strains isolated in Italy from AIDS-patients.
    Fattorini L; Hu CQ; Jin SH; Santoro C; Tsang AY; Mascellino MT; Mandler F; Orefici G
    Zentralbl Bakteriol; 1992 Apr; 276(4):512-20. PubMed ID: 1611208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model.
    Tessier PR; Mattoes HM; Dandekar PK; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2005 Jan; 49(1):188-94. PubMed ID: 15616295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.
    Kohno Y; Ohno H; Miyazaki Y; Higashiyama Y; Yanagihara K; Hirakata Y; Fukushima K; Kohno S
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4071-6. PubMed ID: 17709469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
    Cynamon MH; Carter JL; Shoen CM
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2895-6. PubMed ID: 10991883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.
    Yajko DM; Nassos PS; Sanders CA; Hadley WK
    Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioridazine as Chemotherapy for Mycobacterium avium Complex Diseases.
    Deshpande D; Srivastava S; Musuka S; Gumbo T
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4652-8. PubMed ID: 27216055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
    Brown-Elliott BA; Philley JV; Griffith DE; Thakkar F; Wallace RJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic-based treatment of disseminated Mycobacterium avium.
    Deshpande D; Gumbo T
    Future Microbiol; 2011 Apr; 6(4):433-9. PubMed ID: 21526944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.
    Mehta RT
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1893-902. PubMed ID: 8843300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
    Kosowska K; Credito K; Pankuch GA; Hoellman D; Lin G; Clark C; Dewasse B; McGhee P; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4113-9. PubMed ID: 15504829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
    Mazzariol A; Koncan R; Vitali LA; Cornaglia G
    J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of picolinic acid in combination with the antiprotozoal drug quinacrine against Mycobacterium avium complex.
    Shimizu T; Tomioka H
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3186-8. PubMed ID: 16940126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Azithromycin and Mycobacterium avium infection].
    Perronne C
    Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Macrolide Resistance and Reinfection in Refractory Mycobacterium avium Complex Lung Disease.
    Jhun BW; Kim SY; Moon SM; Jeon K; Kwon OJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2018 Nov; 198(10):1322-1330. PubMed ID: 29877739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species.
    Jalava J; Kataja J; Seppälä H; Huovinen P
    Antimicrob Agents Chemother; 2001 Mar; 45(3):789-93. PubMed ID: 11181362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.